Osiris appoints manager, market access and reimbursement
This article was originally published in Scrip
Stem cell company Osiris Therapeutics has named Therésa K Dixon general manager of market access and reimbursement. She will report directly to Osiris' president and CEO Dr Lode Debrabandere. Prior to joining the Columbia, Maryland-based company, Ms Dixon was vice-president of governing affairs and health economics at Advanced BioHealing (acquired by Shire in 2011).
You may also be interested in...
A rush in the 2010s of high-tech and digital companies focused on women’s health and wellbeing are maturing, adding weight to the more traditional women's health market that has struggled to get attention from investors in the past.
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
A selection of articles you might have missed from September 2020, including exclusive interviews with industry leaders and a review of value-based contract approaches in the US.